fasudil has been researched along with ACD-MPV in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blood, AB | 1 |
| Terry, MH | 1 |
| Merritt, TA | 1 |
| Papamatheakis, DG | 1 |
| Blood, Q | 1 |
| Ross, JM | 1 |
| Power, GG | 1 |
| Longo, LD | 1 |
| Wilson, SM | 1 |
1 other study available for fasudil and ACD-MPV
| Article | Year |
|---|---|
Effect of chronic perinatal hypoxia on the role of rho-kinase in pulmonary artery contraction in newborn lambs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Altitude; Animals; Animals, Newborn; Arterial Pressur | 2013 |